drugset / Trial / NCT01474135
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a double-masked, randomized, controlled study assessing the safety and ocular hypotensive efficacy of two AR 12286/travoprost fixed-dose combination products compared to Travatan® Z in patients with elevated intraocular pressure
Timeline
- Start
- 2011-12
- Primary completion
- 2012-04
- Completion
- 2012-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Travoprost | Other / unclassified | 0.004 % | — |
| Subject | VEROSUDIL | Small molecule | 0.25 % | — |
| Subject | VEROSUDIL | Small molecule | 0.5 % | — |